期刊
NATURE MEDICINE
卷 21, 期 2, 页码 140-149出版社
NATURE PORTFOLIO
DOI: 10.1038/nm.3778
关键词
-
资金
- German Research Foundation (Programm Klinische Studien)
- Alfried Krupp von Bohlen und Halbach-Stiftung
- German Research Foundation [WO 552/9-1, WO 552/10-1]
Paracrine-acting proteins are emerging as a central mechanism by which bone marrow cell based therapies improve tissue repair and heart function after myocardial infarction (MI). We carried out a bioinformatic secretome analysis in bone marrow cells from patients with acute MI to identify novel secreted proteins with therapeutic potential. Functional screens revealed a secreted protein encoded by an open reading frame on chromosome 19 (C19orf10) that promotes cardiac myocyte survival and angiogenesis. We show that bone marrow derived monocytes and macrophages produce this protein endogenously to protect and repair the heart after MI, and we named it myeloid-derived growth factor (MYDGF). Whereas Mydgf-deficient mice develop larger infarct scars and more severe contractile dysfunction compared to wild-type mice, treatment with recombinant Mydgf reduces scar size and contractile dysfunction after MI. This study is the first to assign a biological function to MYDGF, and it may serve as a prototypical example for the development of protein-based therapies for ischemic tissue repair.
作者
我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。
推荐
暂无数据